Haploidentical peripheral-blood stem-cell transplantation for ALK-positive anaplastic large-cell lymphoma - 24/08/11
Doi : 10.1016/S1470-2045(04)01388-9
Arcangelo Liso d, Enrico Tiacci a, Roberto Binazzi e, Karen Pulford f, Roberta Benedetti a, Alessandra Carotti b, Franco Aversa g, Brunangelo Falini c, ⁎ 
a PhD students, Institute of Haematology, University of Perugia, Italy
b staff, Institute of Haematology, University of Perugia, Italy
c Professor of Haematology, Institute of Haematology, University of Perugia, Italy
d Assistant Professor of Haematology, University of Foggia, Italy
e Professor of Orthopaedics at the Instituti Ortopedici Rizzoli, Bologna, Italy
f Research lecturer at the Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford, UK
g Head of the BMT Unit, Policlinico, Monteluce, Perugia, Italy
* Correspondence: Prof Brunangelo Falini, Istituto di Ematologia, Policlinico, Monteluce, 06122 Perugia, Italy. Tel: +31 075 5783190. Fax: +39 075 5783691
© 2004
Elsevier Ltd. Tous droits réservés.
Vol 5 - N° 2
P. 127-128 - février 2004 Retour au numéro
Article précédent
- Haploidentical, non-myeloablative stem-cell transplantation for advanced renal-cell carcinoma
- Makoto Satoh, Koichi Miyamura, Minami Yamada, Shigeto Ishidoya, Richard W Childs, Yoichi Arai
- Clinical trials with moving targets: a commentary on a non-inferiority trial in testicular cancer
- Michael Cullen, Sally Stenning
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?